1 min
ReAlta Raises $40M to Advance HIE Treatment Program
ReAlta raised $40M to advance pegtarazimod, a potential first treatment for hypoxic ischemic encephalopathy in newborns
Health
1 min
Semarion Raises $3.8M to Scale SemaCyte Drug Discovery Platform
Semarion secured $3.8M to scale its SemaCyte platform for automated, data-rich cell-based drug discovery workflows.
1 min
Flourish Care Raises $5.7M to Expand Nationwide Doula Network
Flourish Care raised $5.7M to scale its doula network and expand AI-driven maternal care across the U.S.
2 min
Rivia Raises $15M to Transform Clinical Trials with AI
Rivia raised $15M Series A to expand its AI-powered data engine and agents, aiming to cut clinical trial costs and improve efficiency.
1 min
XCath Raises $30M to Advance Telerobotic Stroke Treatment
XCath secures $30M to develop robotic systems enabling remote stroke treatment and expanding access to neurovascular care.